Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/11830| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Marija Vavlukis | en_US |
| dc.contributor.author | Pop-Gjorceva, Daniela | en_US |
| dc.contributor.author | Lidija Poposka | en_US |
| dc.contributor.author | Emilija Sandevska | en_US |
| dc.contributor.author | Sasko Kedev | en_US |
| dc.date.accessioned | 2021-04-13T09:13:59Z | - |
| dc.date.available | 2021-04-13T09:13:59Z | - |
| dc.date.issued | 2020-12-09 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/11830 | - |
| dc.description.abstract | Accelerated atherosclerosis is widely present in patients with systemic lupus erythematosus. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Bentham Science Publishers Ltd. | en_US |
| dc.relation.ispartof | Current pharmaceutical design | en_US |
| dc.subject | atherosclerosis | en_US |
| dc.subject | atherothrombosis | en_US |
| dc.subject | coronary artery disease | en_US |
| dc.subject | myocardial infarction | en_US |
| dc.subject | outcome | en_US |
| dc.subject | prevalence | en_US |
| dc.subject | sex-specific risk profile | en_US |
| dc.subject | systemic lupus erythematosus | en_US |
| dc.title | Myocardial Infarction in Systemic Lupus Erythematosus - the Sex Specific Risk Profile | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.2174/1381612826666201210110809 | - |
| dc.identifier.volume | 26 | - |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| crisitem.author.dept | Faculty of Medicine | - |
| crisitem.author.dept | Faculty of Medicine | - |
| crisitem.author.dept | Faculty of Medicine | - |
| crisitem.author.dept | Faculty of Medicine | - |
| Appears in Collections: | Faculty of Medicine: Journal Articles | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.